| NCT06782113 | Safety and Efficacy of the UNILEXA Exoskeleton for Regular Verticalization and Assisted Walking | MEBSTER | | - Age ≥ 18 yrs
- Level T5-T12
AIS A, B- All
| Active | 6 | | | Standing/walking/mobility | - 10 Meter Walking Test (10 MWT)
- Adverse Events (AEs)
- Pain Visual Analog Scale (VAS)
- Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0)
- Timed Up and Go Test (TUG)
- World Health Organization Quality of Life- BREF (WHOQOL-BREF)
| 14 weeks | 28 November 2024 | 17 January 2025 | 2 | |
| NCT06794242 | Body Representation and Neuropathic Pain in Spinal Cord Injury | Hospices Civils de Lyon | | - Age 18 - 65 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 80 | | | General health | | 2 weeks | 01 April 2025 | 27 January 2025 | 3 | |
| NCT06793683 | Early BOTOX After Spinal Cord Injury | University of Washington | | - Age 18 - 65 yrs
- Level C1-T6
AIS A, B- ≤ 20 weeks
| By invitation | 10 | EARLY_PHASE1 | Drug | Bladder health/function | - Adverse Events (AEs)
- Feasibility
| 12 months | 27 July 2024 | 27 January 2025 | 1 | |
| NCT06533969 | Assessment of Neural Signals for the Control of Assistive Devices | University of Miami | | - Age ≥ 18 yrs
- Level C4-T1
AIS A, B, C, D- ≥ 6 months
| Recruiting | 3 | NA | Surgery | Arm/hand function | - Brief Pain Inventory (BPI)
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
- Motor Evoked Potentials (MEPs)
- Short Form 36 (SF-36)
- Spinal Cord Independence Measure (SCIM)
- Surface Electromyography (sEMG)
- Toronto Rehabilitation Institute Hand Function Test
| 2 months | 06 September 2024 | 01 August 2024 | 2 | |
| NCT06559618 | Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria | Baylor College of Medicine | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- Require an indwelling (transurethral or suprapubic) or intermittent catheterization for bladder drainage.
- Be currently receiving inpatient or outpatient SCI care at the Baylor College of Medicine
- NOT have medical devices in the urinary tract (other than urinary catheters)
| Recruiting | 30 | PHASE1 | Drug | Bladder health/function | | 35 days | 03 February 2025 | 19 August 2024 | 1 | |
| NCT06587841 | Noninvasive Spinal Cord Stimulation for Early SCI | University of British Columbia | | - Age 19 - 65 yrs
- Level C5-T10
AIS A, B- 3 months - 6 months
- NOT have an implanted cardiac pacemaker, implanted metal in the trunk or spinal cord, intrathecal delivery system (e.g., baclofen pump), or implanted central or peripheral neuromodulator
| Recruiting | 60 | NA | Technology | Bladder health/function | - Bowel and bladder control
- Neurogenic Bladder Symptom Score
| 33 weeks | 01 October 2024 | 19 September 2024 | 1 | |
